Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 2,008.00
+21.50 (1.08%)
Dec 17, 2025, 11:08 AM CET
Genmab Market Cap
Genmab has a market cap or net worth of 122.37 billion as of December 17, 2025. Its market cap has increased by 27.51% in one year.
Market Cap
122.37B
Enterprise Value
101.56B
Revenue
24.48B
Ranking
n/a
PE Ratio
12.43
Stock Price
2,008.00
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 122.37B, an increase of 3,221.40%. That is a compound annual growth rate of 14.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 122.37B | 29.07% |
| Dec 30, 2024 | 94.81B | -32.65% |
| Dec 29, 2023 | 140.77B | -26.77% |
| Dec 30, 2022 | 192.23B | 11.72% |
| Dec 30, 2021 | 172.06B | 6.80% |
| Dec 30, 2020 | 161.11B | 67.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.43T |
| Coloplast | 126.39B |
| ALK-Abelló | 49.55B |
| Demant | 45.20B |
| H. Lundbeck | 41.34B |
| Zealand Pharma | 34.18B |
| Ambu A/S | 23.15B |
| GN Store Nord | 15.81B |